Gefitinib
Brand names,
Gefitinib
Analogs
Gefitinib
Brand Names Mixture
Gefitinib
Chemical_Formula
C22H24ClFN4O3
Gefitinib
RX_link
http://www.rxlist.com/cgi/generic3/iressa.htm
Gefitinib
fda sheet
Gefitinib
msds (material safety sheet)
Gefitinib
Synthesis Reference
No information avaliable
Gefitinib
Molecular Weight
446.902 g/mol
Gefitinib
Melting Point
No information avaliable
Gefitinib
H2O Solubility
Sparingly soluble (<pH4)
Gefitinib
State
Solid
Gefitinib
LogP
3.46
Gefitinib
Dosage Forms
Tablet
Gefitinib
Indication
For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.
Gefitinib
Pharmacology
Gefitinib inhibits the intracellular phosphorylation of numerous tyrosine kinases associated with transmembrane cell surface receptors, including the tyrosine kinases associated with the epidermal growth factor receptor (EGFR-TK). EGFR is expressed on the cell surface of many normal cells and cancer cells.
Gefitinib
Absorption
Absorbed slowly after oral administration with mean bioavailability of 60%.
Gefitinib
side effects and Toxicity
No information avaliable
Gefitinib
Patient Information
Gefitinib
Organisms Affected
Humans and other mammals